Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Gregory Forlenza

Concepts (235)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Infusion Systems
92
2026
480
17.120
Why?
Diabetes Mellitus, Type 1
115
2026
3922
12.290
Why?
Insulin
94
2026
2512
9.340
Why?
Blood Glucose Self-Monitoring
79
2026
701
9.060
Why?
Hypoglycemic Agents
89
2026
1399
8.990
Why?
Pancreas, Artificial
31
2025
97
8.770
Why?
Blood Glucose
104
2026
2341
8.520
Why?
Hypoglycemia
35
2026
479
5.670
Why?
Hyperglycemia
15
2023
379
3.090
Why?
Hematopoietic Stem Cell Transplantation
5
2022
699
1.930
Why?
Diabetes Mellitus
10
2025
1097
1.690
Why?
Monitoring, Ambulatory
5
2018
89
1.610
Why?
Islets of Langerhans Transplantation
5
2024
70
1.600
Why?
Child
66
2026
22707
1.460
Why?
Adolescent
67
2026
22529
1.430
Why?
Algorithms
18
2025
1845
1.360
Why?
Pancreatectomy
5
2024
289
1.360
Why?
Humans
147
2026
145474
1.310
Why?
Insulin-Secreting Cells
3
2023
392
1.250
Why?
Pancreatitis, Chronic
4
2024
64
1.150
Why?
Biomedical Technology
2
2019
50
1.100
Why?
Young Adult
39
2026
14218
1.080
Why?
Verapamil
2
2023
37
0.980
Why?
Diabetes Mellitus, Type 2
8
2025
2588
0.950
Why?
Patient Education as Topic
3
2021
777
0.950
Why?
Adult
56
2026
40777
0.900
Why?
Male
64
2026
72842
0.820
Why?
Technology
5
2023
97
0.780
Why?
Telemedicine
3
2022
961
0.760
Why?
Female
62
2026
78844
0.750
Why?
Calcium Channel Blockers
1
2023
166
0.730
Why?
Caregivers
3
2025
1073
0.690
Why?
Child, Preschool
19
2025
11853
0.680
Why?
Lymphoma
1
2023
237
0.660
Why?
Self-Management
2
2026
202
0.660
Why?
Glucose
9
2024
1048
0.650
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2023
297
0.590
Why?
Patient Dropouts
1
2020
65
0.590
Why?
Treatment Outcome
19
2026
11772
0.580
Why?
Patient Satisfaction
3
2024
709
0.570
Why?
Personal Satisfaction
1
2020
219
0.550
Why?
Diabetic Ketoacidosis
5
2024
209
0.540
Why?
Eczema
1
2018
66
0.530
Why?
Transplantation Conditioning
1
2019
191
0.520
Why?
Betacoronavirus
1
2020
288
0.500
Why?
Diffusion of Innovation
1
2017
96
0.480
Why?
Diabetic Retinopathy
2
2024
209
0.480
Why?
Machine Learning
2
2025
587
0.450
Why?
Endocrine Glands
1
2015
14
0.450
Why?
Insulin, Regular, Human
7
2023
47
0.450
Why?
Quality of Life
4
2024
3204
0.440
Why?
Endocrine System Diseases
1
2015
35
0.440
Why?
Transplantation, Autologous
4
2024
300
0.440
Why?
Insulin Lispro
3
2024
42
0.440
Why?
Retrospective Studies
13
2025
17291
0.430
Why?
Pneumonia, Viral
1
2020
389
0.430
Why?
Aged
21
2026
26153
0.430
Why?
Coronavirus Infections
1
2020
383
0.430
Why?
C-Peptide
3
2025
190
0.430
Why?
Exercise
9
2025
2198
0.420
Why?
Artificial Intelligence
1
2019
381
0.410
Why?
Fanconi Anemia
1
2013
11
0.410
Why?
United States
16
2026
16098
0.410
Why?
Dwarfism
1
2013
14
0.410
Why?
Cross-Over Studies
7
2026
608
0.400
Why?
Growth Hormone
1
2013
91
0.400
Why?
Awareness
2
2026
110
0.400
Why?
Skin
1
2018
753
0.390
Why?
Middle Aged
24
2026
36215
0.380
Why?
Blindness
1
2012
51
0.370
Why?
Sequence Analysis, DNA
1
2015
777
0.360
Why?
Suicide
1
2020
728
0.360
Why?
High-Throughput Nucleotide Sequencing
1
2015
530
0.350
Why?
Pandemics
1
2020
1707
0.340
Why?
Angiogenesis Inhibitors
1
2012
238
0.330
Why?
Biosensing Techniques
2
2025
142
0.330
Why?
Calibration
3
2020
152
0.320
Why?
Lingual Frenum
1
2010
2
0.320
Why?
Tongue Diseases
1
2010
9
0.320
Why?
Failure to Thrive
1
2010
28
0.320
Why?
Cardiovascular Diseases
1
2022
2187
0.310
Why?
Epidemics
1
2011
96
0.310
Why?
Randomized Controlled Trials as Topic
1
2016
1747
0.310
Why?
Vascular Endothelial Growth Factor A
1
2012
552
0.310
Why?
Medicaid
3
2022
467
0.300
Why?
Medicare
3
2025
903
0.300
Why?
Models, Biological
1
2016
1764
0.290
Why?
Double-Blind Method
4
2023
2062
0.280
Why?
Infant
6
2023
10077
0.280
Why?
Skiing
2
2019
49
0.260
Why?
Follow-Up Studies
5
2021
5423
0.260
Why?
Adolescent Nutritional Physiological Phenomena
2
2017
29
0.260
Why?
Inventions
2
2018
19
0.250
Why?
Prospective Studies
7
2025
8057
0.250
Why?
Insurance Coverage
2
2025
244
0.240
Why?
Endocrinology
2
2018
77
0.230
Why?
Feasibility Studies
6
2026
1111
0.230
Why?
Meals
4
2024
130
0.230
Why?
Insulin Aspart
2
2022
30
0.230
Why?
Outpatients
2
2021
447
0.220
Why?
Injections, Subcutaneous
3
2020
170
0.220
Why?
Overweight
2
2023
614
0.220
Why?
Risk Factors
5
2020
10885
0.220
Why?
Postoperative Complications
2
2015
2970
0.210
Why?
Body Height
2
2017
202
0.210
Why?
Mutation
1
2015
4075
0.200
Why?
Insulins
1
2023
38
0.180
Why?
Equipment Failure
3
2018
115
0.180
Why?
Eligibility Determination
1
2022
72
0.180
Why?
Patient Safety
1
2025
356
0.180
Why?
Pediatrics
2
2020
1121
0.170
Why?
Automobile Driving
1
2023
157
0.160
Why?
Infusion Pumps, Implantable
1
2020
26
0.160
Why?
Computer Systems
1
2020
55
0.150
Why?
Europe
3
2025
418
0.150
Why?
Smartphone
2
2019
106
0.150
Why?
Sports
2
2019
211
0.150
Why?
Product Surveillance, Postmarketing
1
2019
74
0.150
Why?
Fatal Outcome
1
2020
305
0.150
Why?
Reproducibility of Results
4
2024
3413
0.140
Why?
Prevalence
3
2023
2865
0.140
Why?
Clinical Alarms
1
2017
11
0.130
Why?
Software
2
2021
680
0.130
Why?
Night Terrors
1
2017
1
0.130
Why?
Insulinoma
1
2017
29
0.130
Why?
Device Approval
1
2017
19
0.130
Why?
Diet, Diabetic
1
2017
33
0.130
Why?
Voluntary Health Agencies
1
2016
6
0.130
Why?
Survival Analysis
1
2020
1374
0.130
Why?
Adrenal Hyperplasia, Congenital
1
2017
39
0.120
Why?
Program Evaluation
1
2021
943
0.120
Why?
Pancreaticoduodenectomy
1
2017
137
0.120
Why?
United States Food and Drug Administration
1
2017
208
0.120
Why?
Obesity
3
2023
3116
0.120
Why?
Statistics as Topic
1
2016
283
0.120
Why?
Abdominal Pain
1
2017
149
0.110
Why?
Hypophosphatasia
1
2015
5
0.110
Why?
Age Factors
3
2018
3342
0.110
Why?
Drug Overdose
1
2020
374
0.110
Why?
Automation
2
2025
104
0.110
Why?
Drug Delivery Systems
1
2018
381
0.110
Why?
Alkaline Phosphatase
1
2015
144
0.110
Why?
History, 21st Century
2
2025
222
0.100
Why?
Autografts
1
2014
55
0.100
Why?
Pilot Projects
2
2020
1891
0.100
Why?
Health Services Accessibility
1
2022
1101
0.100
Why?
History, 20th Century
2
2025
328
0.100
Why?
Choristoma
1
2013
20
0.100
Why?
Glucose Clamp Technique
1
2014
199
0.100
Why?
Primary Ovarian Insufficiency
1
2013
40
0.100
Why?
Postoperative Period
1
2014
351
0.100
Why?
Infusions, Intravenous
1
2014
428
0.100
Why?
Pituitary Gland
1
2013
149
0.100
Why?
Clinical Decision-Making
1
2016
363
0.100
Why?
Graft Survival
1
2015
518
0.100
Why?
Allografts
1
2013
152
0.090
Why?
Bionics
2
2022
14
0.090
Why?
Patient Compliance
1
2017
587
0.090
Why?
Clinical Protocols
1
2014
280
0.090
Why?
Surveys and Questionnaires
2
2024
6066
0.090
Why?
Genetic Testing
1
2015
480
0.090
Why?
Graft Rejection
1
2015
521
0.090
Why?
Quality Improvement
1
2021
1295
0.090
Why?
Adolescent Behavior
1
2017
494
0.090
Why?
Pituitary Neoplasms
1
2013
190
0.090
Why?
Adipose Tissue
1
2016
645
0.090
Why?
Body Mass Index
2
2017
2445
0.090
Why?
Prognosis
2
2020
4316
0.080
Why?
Age of Onset
1
2012
555
0.080
Why?
Longitudinal Studies
3
2024
2953
0.080
Why?
Biomedical Research
1
2016
717
0.080
Why?
Critical Illness
1
2016
900
0.070
Why?
Activities of Daily Living
3
2017
444
0.070
Why?
Global Health
1
2012
403
0.070
Why?
Pancreatic Neoplasms
1
2017
928
0.070
Why?
Consensus
2
2022
477
0.070
Why?
Biomarkers
1
2020
4295
0.070
Why?
Electronic Health Records
1
2016
1196
0.070
Why?
Guideline Adherence
1
2012
586
0.070
Why?
Case-Control Studies
1
2015
3623
0.070
Why?
Equipment Design
2
2019
525
0.070
Why?
Societies, Medical
2
2024
899
0.060
Why?
Hospitalization
3
2024
2460
0.060
Why?
Infant, Newborn
1
2019
6447
0.060
Why?
Cold Temperature
2
2019
206
0.060
Why?
Weight Gain
1
2010
561
0.060
Why?
Breast Feeding
1
2010
446
0.060
Why?
Disposable Equipment
1
2026
24
0.060
Why?
Time Factors
3
2025
7123
0.060
Why?
Incidence
1
2012
2923
0.060
Why?
Seasons
2
2019
538
0.060
Why?
Practice Guidelines as Topic
1
2012
1581
0.050
Why?
Risk
2
2017
919
0.050
Why?
Child Abuse
1
2010
552
0.050
Why?
Combined Modality Therapy
2
2017
1266
0.050
Why?
Mass Screening
1
2012
1360
0.050
Why?
Diet
1
2011
1277
0.050
Why?
Bayes Theorem
1
2025
420
0.050
Why?
Quality-Adjusted Life Years
1
2023
123
0.050
Why?
Insulin Resistance
1
2011
1244
0.050
Why?
Standard of Care
1
2023
81
0.050
Why?
Pregnancy
2
2025
7202
0.040
Why?
Aged, 80 and over
2
2026
8333
0.040
Why?
Reference Standards
1
2021
177
0.040
Why?
Cohort Studies
2
2025
6013
0.040
Why?
Intention to Treat Analysis
1
2020
79
0.040
Why?
Cost-Benefit Analysis
1
2023
639
0.040
Why?
Pancreas
1
2022
341
0.040
Why?
Social Conditions
1
2019
13
0.040
Why?
Inpatients
1
2024
553
0.040
Why?
Disease Management
1
2023
653
0.040
Why?
Equipment and Supplies
1
2018
36
0.040
Why?
Health Personnel
1
2025
754
0.030
Why?
International Cooperation
1
2018
197
0.030
Why?
Postprandial Period
1
2018
114
0.030
Why?
Virginia
1
2017
57
0.030
Why?
Snacks
1
2017
22
0.030
Why?
Colorado
2
2017
4553
0.030
Why?
Reference Values
1
2018
798
0.030
Why?
Ohio
1
2017
146
0.030
Why?
Mobile Applications
1
2020
199
0.030
Why?
Child Nutritional Physiological Phenomena
1
2017
106
0.030
Why?
Minnesota
1
2017
168
0.030
Why?
Accelerometry
1
2017
118
0.030
Why?
Single-Blind Method
1
2017
318
0.030
Why?
Hypertrophy
1
2016
128
0.030
Why?
Food Preferences
1
2017
126
0.030
Why?
Materials Testing
1
2017
345
0.030
Why?
Healthcare Disparities
1
2022
735
0.030
Why?
Child Behavior
1
2017
236
0.030
Why?
Pain Measurement
1
2017
561
0.030
Why?
Feeding Behavior
1
2018
690
0.020
Why?
Practice Patterns, Physicians'
1
2018
1371
0.020
Why?
Severity of Illness Index
1
2017
2930
0.020
Why?
Magnetic Resonance Imaging
1
2017
3904
0.010
Why?
Forlenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)